Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2017
RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric studyChristophe Massard, Isabelle Borget, Françoise Farace, et al.
Cancer Research|August 19, 2016
Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA MutationsYu Fu, Cécile Jovelet, Thomas Filleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomasStéphanie Puget, Jacques Grill, Alexander Valent, et al.
Tumori|May 2, 2018
Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plasticaLinda Mahjoubi, Fabiola Cecchi, Christophe Massard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast CancersElie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2018
Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?Clara Prud'homme, Fréderic Deschamps, Adrien Allorant, et al.
Breast Cancer Research and Treatment|February 25, 2016
Whole exome sequencing of rare aggressive breast cancer histologiesMaria Vittoria Dieci, Veronika Smutná, Véronique Scott, et al.
JTO Clinical and Research Reports|September 30, 2021
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung TrialJordi Remon, Benjamin Besse, Alexandra Leary, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trialRaphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2017
RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric studyChristophe Massard, Isabelle Borget, Françoise Farace, et al.
Cancer Research|August 19, 2016
Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA MutationsYu Fu, Cécile Jovelet, Thomas Filleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomasStéphanie Puget, Jacques Grill, Alexander Valent, et al.
Tumori|May 2, 2018
Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plasticaLinda Mahjoubi, Fabiola Cecchi, Christophe Massard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast CancersElie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2018
Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?Clara Prud'homme, Fréderic Deschamps, Adrien Allorant, et al.
Breast Cancer Research and Treatment|February 25, 2016
Whole exome sequencing of rare aggressive breast cancer histologiesMaria Vittoria Dieci, Veronika Smutná, Véronique Scott, et al.
JTO Clinical and Research Reports|September 30, 2021
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung TrialJordi Remon, Benjamin Besse, Alexandra Leary, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trialRaphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Pageof 18